SKIN is trading 40% up at $1.06 today after its SkinStylus SteriLock MicroSystem received new FDA clearance for the improvement of periorbital wrinkles for all skin types.

  • This makes SkinStylus the only microneedling device with three FDA-cleared indications, reinforcing SkinHealth System's commitment to science-backed innovation.
  • The FDA clearance is expected to better position the company in the rapidly growing microneedling market, estimated at $330 million in 2025.